期刊文献+

SiRNA沉默HLA-A2表达的人骨髓间充质干细胞对人异体T淋巴细胞分泌功能及其诱导成骨能力的影响

Effects of RNA silenced HLA-A2 in hBMSCs on secretory function of human allogeneic T lymphocytes and osteogenic ability of hBMSCs *
暂未订购
导出
摘要 目的:探讨应用RNAi技术沉默HLA-A2表达的人骨髓间充质干细胞(hBMSCs)对人异体T淋巴细胞分泌功能的调节作用及诱导成骨能力的影响。方法:用siRNA转染至第3代hBMSCs将转染前、后各组的hBMSCs与PHA刺激的人异体T淋巴细胞共同培养,用ELISA检测各培养组上清液γ干扰素(IFN-γ)、白细胞介素2(IL-2)的水平;对2组细胞进行成骨诱导分化培养,观察细胞形态变化;碱性磷酸酶染色、计数和Von-Kossa染色、计数检测成骨能力。结果:hBMSCs表面抗原CD44、CDl66阳性。转染前hBMSCs的HLA-A2表达为阳性,转染后hBMSCs的HLA-A2表达为弱阳性;转染前hBMSCs的HLA-A2蛋白表达量高于转染后的HLA-A2蛋白表达量。转染前、后的hBMSCs均能抑制人T淋巴细胞分泌IFN-γ、IL-2,转染前、后比较有差异。ALP染色显示转染前、后的hBMSCs均出现胞质呈棕黑色的阳性反应,ALP活性检测结果显示2组之间无差异。Von-Kossa染色显示转染前、后的hBMSCs均有钙结节形成,统计2组之间无差异。结论:应用RNAi技术沉默HLA-A2表达的hBMSCs可以抑制PHA刺激人T淋巴细胞分泌因子IFN-γ、IL-2的水平,转染后的hBMSCs比未转染的hBMSCs抑制作用更强。应用RNAi技术沉默HLA-A2表达的hBMSCs,不影响其成骨能力。 Objective: To explore the secretory function of human allogeneic T lymphocytes cocultured with human bone mar- row derived mesenchymal stem cells (hBMSCs), in which the HLA-A2 gene was silenced using RNA interference, and, to observe the influence of this RNA interference on osteogenic ability of hBMSCs. Methods: The hBMSCs were harvested and identified. And, human allogeneic T lymphocytes stimulated by PHA were cocultured with 1st to 3rd passaged hBMSCs before and after transferred with siRNA targeting HLA-A2. 72 h later, the levels of IFN-'/and IL-2 secreted from human allogeneic T lympho- cytes were detected using ELISA. Subsequently, the osteogenic induction of hBMSCs with and without RNA interference was per- formed in vitro. The osetogenic ability was judged by alkaline phosphatase (ALP) staining and Von-Kossa staining. Results: The cultured hBMSCs were CIN4 and CD166 positiv~ The RNA interference targeting HLA-A2 induced a significant down-regulation of HLA-A2 in hBMSCs. The levels of IFN-7 and IL-2 were decreased from human allogeneic T lymphocytes cocultured with trans- ferred or non-transferred hBM^s, especially with transferred ones. No difference was found both in ALP and Von-Kossa staining. Conclusion: The HLA-A2 silence in hBMSCs has stronger inhibition on IFN-7 and IL-2 secreted from human allogeneic T lympho- cytes than non-transferred hBM^s, but has no effects on its ostogenic ability.
出处 《解剖学杂志》 CAS CSCD 北大核心 2012年第2期145-148,F0002,共5页 Chinese Journal of Anatomy
基金 辽宁省教育厅基金(LT2010061) 辽宁省自然科学基金(20102138) 辽宁医学院青年科技启动基金(Y2010z.04)
关键词 骨髓间充质干细胞 RNAI技术 T淋巴细胞 分泌功能 成骨能力 mesenchymal stem cells RNAi technology T lymphocyte secretory function osteogenetic ability
  • 相关文献

参考文献8

二级参考文献43

  • 1江小霞,张毅,李秀森,吴英,于晓妉,唐佩弦,毛宁.间充质干细胞对T淋巴细胞转化的影响[J].解放军医学杂志,2005,30(2):130-132. 被引量:10
  • 2陆晓茜,刘霆,孟文彤,朱焕玲,席亚明,刘咏梅.人骨髓间充质干细胞对T淋巴细胞的免疫调节作用[J].中国实验血液学杂志,2005,13(4):651-655. 被引量:15
  • 3王艺蕾,晏晓明.大鼠异体角膜缘移植排斥的实验研究[J].眼科研究,2005,23(4):361-364. 被引量:2
  • 4Schreuder GM, Hurley CK, Marsh SG, et al. The HLA Dictionary2001: a summary of HLA-A,-B,-C,-DRB1/3/4/5,-DQB1 alleles and their association with serologically defined HLA- A, - B, - C, - DR and - DQ antigens. Tissue Antigens,2001,58 ( 2 ): 109-140.
  • 5Mami Chouaib F,Echchakir H, Dorothee G, et al. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. Immunol Rev,2002,188:114-121.
  • 6Eifuku R,Takenoyama M,Yoshino I,et al. Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes. Int J Clin Oncol,2001,6( 1 ) :34-39.
  • 7Cabrera T, Lopez Nevot MA, Gaforio JJ, et al. Analysis of HLA expression in human tumor tissues. Cancer Immunol Immunother,2003,52(1) :1-9.
  • 8Cohen CJ, Denkberg G, Lev A, et al. Recombinant antibodies with MHC-restricted peptide-specific, T-cell receptor-like specificity:new tools to study antigen presentation and TCR-peptide-MHC interactions. J Mol Recognit ,2003,16 ( 5 ) :324-332.
  • 9Novak E J, Liu AW, Gebe JA, et al. Tetramer- guided epitope mapping:rapid identification and characterization of immunodominant CD4 + T cell epitopes from complex antigens. J Immunol, 2001,166 ( 11 ):6665 -6670.
  • 10Sette A, Chesnut R C,John Fikes J. HLA expression in cancer :Implications for T cell-based immunotherapy. Immunogenetics, 2001,53(4) :255-263.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部